Home | Publications | Medical Devices place holder
place holder place holder

Medical Devices


Germany Ent Devices Investment Opportunities

Analysis and Forecasts to 2012

Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   97
ISBN Number   not applicable
Product Code   GMD1155
Ask a question about this product?

Price £1,045.00

approximately: $1,603 | €1,229

Summary


Germany ENT Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Germany ENT devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ENT devices in Germany.

Scope

  • The report provides ENT devices information broken down into detailed categories and segments in Germany.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the ENT devices market in Germany.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 ENT Devices
    • 3.2 Hearing Aid Devices
      • 3.2.1 Analog Hearing Devices
      • 3.2.2 Digital Signal Processing Hearing Aid (DSP)
    • 3.3 Hearing Implants
      • 3.3.1 Cochlear Implant
      • 3.3.2 Bone Anchored Hearing Implant
    • 3.4 Diagnostic Devices
      • 3.4.1 Audiometer
      • 3.4.2 Otoscope
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Sector
    • 4.2 Healthcare Expenditure
    • 4.3 Healthcare Infrastructure
      • 4.3.1 Healthcare Personnel Data
      • 4.3.2 Healthcare Facilities Data
    • 4.4 Healthcare Policy
  • 5 Regulation System
    • 5.1 Regulation System
    • 5.2 Medical Equipment Approval Process
      • 5.2.1 Classification of Medical Devices
    • 5.3 Conformity Assessment Process
      • 5.3.1 Class I devices
      • 5.3.2 Class IIa devices
      • 5.3.3 Class IIb devices
      • 5.3.4 Class III devices
    • 5.4 Post Market Surveillance
  • 6 Pricing and Reimbursement
    • 6.1 SHI
      • 6.1.1 Private Health Insurance
      • 6.1.2 Diagnosis Related Groups (DRG)
  • 7 Distribution Structure
  • 8 Germany Medical Equipment Cross Market Comparison
  • 9 ENT Devices Cross Country Comparison
  • 10 ENT Devices In Germany
    • 10.1 ENT Devices Overall Revenues by Category (2000-2012)
    • 10.2 ENT Devices Overall Volume by Category (2000-2012)
    • 10.3 ENT Devices Overall Company Share (2006-2007)
  • 11 Diagnostic Devices In Germany
    • 11.1 Diagnostic Devices Revenues by Segment (2000-2012)
    • 11.2 Diagnostic Devices Volume by Segment (2000-2012)
    • 11.3 Diagnostic Devices Average Price (2000-2012)
    • 11.4 Diagnostic Devices Distribution Share (2006-2007)
    • 11.5 Diagnostic Devices Company Share (2006-2007)
  • 12 Hearing Aid Devices In Germany
    • 12.1 Hearing Aid Devices Revenues by Segment (2000-2012)
    • 12.2 Hearing Aid Devices Volume by Segment (2000-2012)
    • 12.3 Hearing Aid Devices Average Price (2000-2012)
    • 12.4 Hearing Aid Devices Distribution Share (2006-2007)
    • 12.5 Hearing Aid Devices Company share (2006-2007)
  • 13 Hearing Implants In Germany
    • 13.1 Hearing Implants Revenues by Segment (2000-2012)
    • 13.2 Hearing Implants Volume by Segment (2000-2012)
    • 13.3 Hearing Implants Average Price (2000-2012)
    • 13.4 Hearing Implants Distribution Share (2006-2007)
    • 13.5 Hearing Implants Company share (2006-2007)
  • 14 Phonak Holding AG Company Profile
    • 14.1 Company Overview
    • 14.2 Value Chain Analysis
      • 14.2.1 Manufacturing
        • 14.2.1.1 In House Manufacturing
      • 14.2.2 Product Development
        • 14.2.2.1 Regulatory Approvals
        • 14.2.2.2 Clinical Trials
        • 14.2.2.3 Research and Development
      • 14.2.3 Sales and Marketing
        • 14.2.3.1 Partnerships and Alliances
        • 14.2.3.2 E-distribution
  • 15 William Demant Holding A/S Company Profile
    • 15.1 Company Overview
    • 15.2 Value Chain Analysis
      • 15.2.1 Manufacturing
        • 15.2.1.1 In House Manufacturing
      • 15.2.2 Product Development
        • 15.2.2.1 Regulatory Approvals
        • 15.2.2.2 Clinical Trials
        • 15.2.2.3 Research and Development
      • 15.2.3 Sales and Marketing
        • 15.2.3.1 Partnerships and Alliances
  • 16 Cochlear Limited Company Profile
    • 16.1 Company Overview
    • 16.2 Value Chain Analysis
      • 16.2.1 Manufacturing
        • 16.2.1.1 In House Manufacturing
      • 16.2.2 Product Development
        • 16.2.2.1 Regulatory Approvals
        • 16.2.2.2 Clinical Trials
        • 16.2.2.3 Research and Development
      • 16.2.3 Sales and Marketing
        • 16.2.3.1 Partnerships and Alliances
        • 16.2.3.2 Licensing Agreements
        • 16.2.3.3 E-distribution
  • 17 GN ReSound A/S Company Profile
    • 17.1 Company Overview
  • 18 Siemens Medical Solutions Company Profile
    • 18.1 Company Overview
    • 18.2 Value Chain Analysis
      • 18.2.1 Manufacturing
        • 18.2.1.1 In House Manufacturing
        • 18.2.1.2 Outsourcing
      • 18.2.2 Product Development
        • 18.2.2.1 Regulatory Approvals
        • 18.2.2.2 Clinical Trials
        • 18.2.2.3 Research and Development
      • 18.2.3 Sales and Marketing
        • 18.2.3.1 Partnerships and Alliances
        • 18.2.3.2 E-distribution
  • 19 Starkey Laboratories, Inc. Company Profile
    • 19.1 Company Overview
  • 20 Celon AG medical instruments Company Profile
    • 20.1 Company Overview
  • 21 Dreve Otoplastik GmbH Company Profile
    • 21.1 Company Overview
  • 22 TRACOE medical GmbH Company Profile
    • 22.1 Company Overview
  • 23 Appendix
    • 23.1 Global Markets Direct Research Methodology
    • 23.2 Coverage
    • 23.3 Secondary Research
    • 23.4 Primary Research
    • 23.5 Models
    • 23.6 Forecasts
    • 23.7 Expert Panels
    • 23.8 Currency Conversion
    • 23.9 Contact Us
    • 23.10 Disclaimer
  • LIST OF TABLES
  • 1 List of Tables
    • Table 1: Healthcare Personnel by Region in Germany, 2004
    • Table 2: Doctors by Specialty in Germany, 2000-2004
    • Table 3: Hospitals by Region in Germany, 2004
    • Table 4: Hospital Beds by Region in Germany, 2004
    • Table 5: Rehabilitation Centers by Region in Germany, 2004
    • Table 6: Rehabilitation Center Beds by Region in Germany, 2004
    • Table 7: Discharges by Diagnosis in Germany, 2004
    • Table 8: Germany, Medical Equipment Market Comparison
    • Table 9: ENT Devices Cross Country Comparison (2000-2012)
    • Table 10: ENT Devices, Germany, Category Revenues ($ mn), 2000-2012
    • Table 11: Ophthalmic Devices Market, Germany, Portfolio Analysis
    • Table 12: ENT Devices, Germany, Category Revenues ($ mn), Historic, 2000-2007
    • Table 13: ENT Devices, Germany, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 14: ENT Devices, Germany, Category Volume (Units), 2000-2012
    • Table 15: ENT Devices, Germany, Category Volume (Units), Historic, 2000-2007
    • Table 16: ENT Devices, Germany, Category Volume (Units), Forecast, 2007-2012
    • Table 17: ENT Devices, Germany, Overall Company Share by Revenue, 2006-2007
    • Table 18: Diagnostic Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 19: Diagnostic Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 20: Diagnostic Devices, Germany, Volume (Units) by Segment, Historic, 2000-2007
    • Table 21: Diagnostic Devices, Germany, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 22: Diagnostic Devices, Germany, Average Price ($), Historic, 2000-2007
    • Table 23: Diagnostic Devices, Germany, Average Price ($), Forecast,, 2007-2012
    • Table 24: Diagnostic Devices, Germany, Distribution Share by Revenue, 2006-2007
    • Table 25: Diagnostic Devices, Germany, Company share by Revenue ($ mn), 2006-2007
    • Table 26: Hearing Aid Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 27: Hearing Aid Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 28: Hearing Aid Devices, Germany, Volume (Units) by Segment, Historic, 2000-2007
    • Table 29: Hearing Aid Devices, Germany, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 30: Hearing Aid Devices, Germany, Average Price ($), Historic, 2000-2007
    • Table 31: Hearing Aid Devices, Germany, Average Price ($), Forecast,, 2007-2012
    • Table 32: Hearing Aid Devices, Germany, Distribution Share by Revenue, 2006-2007
    • Table 33: Hearing Aid Devices, Germany Company share by Revenue ($ mn), 2006-2007
    • Table 34: Hearing Implants, Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 35: Hearing Implants, Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 36: Hearing Implants, Germany, Volume (Units) by Segment, Historic, 2000-2007
    • Table 37: Hearing Implants, Germany, Volume (Units) by Segment, Forecast, 2007-2012
    • Table 38: Hearing Implants, Germany, Average Price ($), Historic, 2000-2007
    • Table 39: Hearing Implants, Germany, Average Price ($), Forecast,, 2007-2012
    • Table 40: Hearing Implants, Germany, Distribution Share by Revenue, 2006-2007
    • Table 41: Hearing Implants, Germany Company share by Revenue ($ mn), 2006-2007
    • Table 42: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • LIST OF FIGURES
    • 1.2 List of Figures
    • Figure 1: Healthcare Structure in Germany, 2000 - 2006
    • Figure 2: Healthcare Expenditure Sources in Germany, 2003
    • Figure 3: Healthcare Financing Framework in Germany, 2007
    • Figure 4: Flowchart for Classification of Non-invasive Devices in Germany, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in Germany, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in Germany, 2007
    • Figure 7: Classification of Invasive Devices in Germany, 2007
    • Figure 8: Classification of Invasive Devices in Germany, 2007
    • Figure 9: Flowchart for Classification of Active Devices in Germany, 2007
    • Figure 10: Flowchart for Classification of Active Devices in Germany, 2007
    • Figure 11: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007
    • Figure 12: Conformity Assessment of Class-I Medical Devices in Germany, 2007
    • Figure 13: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007
    • Figure 14: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007
    • Figure 15: Conformity Assessment of Class-III Medical Devices in Germany, 2007
    • Figure 16: Germany, Medical Equipment Market Comparison,2007
    • Figure 17: ENT Devices Cross Country Comparison (2000-2012)
    • Figure 18: ENT Devices Market, Country Comparison
    • Figure 19: ENT Devices, Germany, Category Revenues ($ mn), 2000-2012
    • Figure 20: ENT Devices Market, Germany, Portfolio Analysis
    • Figure 21: ENT Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 22: ENT Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 23: ENT Devices, Germany, Overall Company Share (%), 2007
    • Figure 24: Diagnostic Devices, Germany, Revenue ($ mn) by Segment , Historic, 2000-2007
    • Figure 25: Diagnostic Devices, Germany, Revenue ($ mn) by Segment , Forecast, 2007-2012
    • Figure 26: Diagnostic Devices, Germany, Overall Volume (Units), Historic, 2000-2007
    • Figure 27: Diagnostic Devices, Germany, Overall Volume (Units), Forecast, 2007-2012
    • Figure 28: Diagnostic Devices, Germany Company share (%), 2007
    • Figure 29: Hearing Aid Devices, Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 30: Hearing Aid Devices, Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 31: Hearing Aid Devices, Germany, Volume (Units) by Segment, Historic, 2000-2007
    • Figure 32: Hearing Aid Devices, Germany, Volume (Units) by Segment, Forecast, 2007-2012
    • Figure 33: Hearing Aid Devices, Germany Company share (%), 2007
    • Figure 34: Hearing Implants, Germany, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 35: Hearing Implants, Germany, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 36: Hearing Implants, Germany, Volume (Units) by Segment, Historic, 2000-2007
    • Figure 37: Hearing Implants, Germany, Volume (Units) by Segment, Forecast, 2007-2012
    • Figure 38: Hearing Implants, Germany Company share (%), 2007
    • Figure 39: Phonak Holding AG Value Chain Analysis
    • Figure 40: William Demant Holding A/S Value Chain Analysis
    • Figure 41: Cochlear Limited Value Chain Analysis
    • Figure 42: Siemens Medical Solutions Value Chain Analysis
    • Figure 43: Global Markets Direct Methodology